DOCK8 and B-cell chronic lymphocytic leukemia: We show that the ligand of Siglec-6 (sTn) is overexpressed on CLL patient-derived BMSCs and our studies suggest that sTn stimulation leads to Cdc42 activation and actin polymerization via a Siglec-6-DOCK8-dependent axis.